Gujasit 15/100mg Tablet

Gujasit 15/100mg Tablet is a combination medication used for the management of type 2 diabetes mellitus. It contains two active ingredients: Ertugliflozin & Sitagliptin. This combination provides complementary mechanisms of action to help lower blood sugar levels and improve glycemic control.

Key Ingredients:

• Ertugliflozin: Ertugliflozin belongs to a class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels.
• Sitagliptin: Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones in the body, which stimulate the pancreas to produce more insulin and reduce the amount of glucose produced by the liver.

Uses:

• Type 2 Diabetes Management: Gujasit 15/100mg Tablet is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. The combination of Ertugliflozin and Sitagliptin helps lower blood sugar levels through complementary mechanisms of action.

Administration:

• Gujasit 15/100mg Tablet is typically taken orally, once daily, with or without food, as directed by a healthcare professional.
• The dosage may vary depending on individual patient factors such as kidney function, response to treatment, and other medications being taken for diabetes management.
• It is crucial to follow the prescribed regimen provided by the healthcare provider to achieve optimal glycemic control and reduce the risk of complications associated with diabetes.

Precautions:

• Before starting treatment with Gujasit 15/100mg Tablet, inform your healthcare provider about any existing medical conditions, especially kidney problems or a history of diabetic ketoacidosis.
• Inform your healthcare provider about all medications, supplements, and herbal products you are currently taking, as they may interact with Ertugliflozin and Sitagliptin.
• Monitor blood sugar levels regularly as directed by your healthcare provider while taking Gujasit 15/100mg Tablet to ensure effective glycemic control.
• Report any signs of adverse effects such as urinary tract infections, genital yeast infections, or symptoms of hypoglycemia (low blood sugar) to your healthcare provider promptly.

In Conclusion:

Gujasit 15/100mg Tablet, containing a combination of Ertugliflozin and Sitagliptin, offers a comprehensive approach to managing type 2 diabetes mellitus. By targeting multiple pathways involved in glucose regulation, it helps lower blood sugar levels and improve overall glycemic control.